Bangkok Dusit Medical Services Public Company Limited (SET: BDMS) has announced its 2Q24 consolidated financial statement through the Stock Exchange of Thailand as follows;
| Quarter | 2Q24 | 2Q23 |
| Net Profit (Loss)
Million Baht |
3,334.87 | 3,051.73 |
| Earning Per Share
(Baht) |
0.2100 | 0.1900 |
| % Change | 9.28 | |
| 6 Months | 2024 | 2023 |
| Net Profit (Loss)
Million Baht |
7,408.37 | 6,519.54 |
| Earning Per Share (Baht) | 0.4700 | 0.4100 |
| % Change | 13.63 | |
BDMS reported a net profit in 2Q24 of Baht 3,335 million, increased by 9% YoY, due mainly to growth of Thai and international patients. Effective financial management also helped reduce interest expenses. Moreover, income tax expenses decreased in 2Q24 due to tax privileges received from the Board of Investment (BOI).
The company and subsidiaries reported consolidated operating income for 2Q24 of Baht 26,058 million, an increase of 7% YoY. The growth was mainly attributable to an increase in revenue from hospital operations of 7% YoY, which was driven by Thai patient revenue growth of 5% YoY together with international patient revenue growth of 11% YoY.
For the six-month period ended 30 June 2024, the consolidated operating income was Baht 52,987 million, increased by 9% YoY, and a net profit of Baht 7,408 million, increased by 14% YoY. The growth was attributable to an increase in revenue from hospital operations of 9% YoY, driven mainly by strong growth of 7% YoY from Thai patient revenues and 12% YoY from international patient revenues.
EBITDA in 2Q24 stood at Baht 5,751 million, increased by 4% from 2Q23, but EBITDA margin decreased from 22.6% in 2Q23 to 22.1% in 2Q24, due to lower occupancy rate and economies of scale. As for 6M24, EBITDA of Baht 12,528 million, increased by 9% YoY, while EBITDA margin remained unchanged at 23.6%.
